product summary
company name :
Leica Biosystems
other brands :
Novocastra, Surgipath
product type :
antibody
product name :
Anti-Rat Myosin Heavy Chain Monoclonal Antibody, Unconjugated
catalog :
NCL-MHCd
clonality :
monoclonal
conjugate :
nonconjugated
reactivity :
human, dogs
application :
immunohistochemistry, immunohistochemistry - frozen section
more info or order :
citations: 10
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - frozen section; human; fig 1
Janghra N, Morgan J, Sewry C, Wilson F, Davies K, Muntoni F, et al. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies. PLoS ONE. 2016;11:e0150818 pubmed publisher
  • immunohistochemistry; dogs
  • immunohistochemistry; human
Martin P, Golden B, Okerblom J, Camboni M, Chandrasekharan K, Xu R, et al. A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle. PLoS ONE. 2014;9:e88226 pubmed publisher
Israeli D, Poupiot J, Amor F, Charton K, Lostal W, Jeanson Leh L, et al. Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies. Sci Rep. 2016;6:28097 pubmed publisher
Toh Z, Thandar Aung Htut M, Pinniger G, Adams A, Krishnaswarmy S, Wong B, et al. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies. PLoS ONE. 2016;11:e0145620 pubmed publisher
Larcher T, Lafoux A, Tesson L, Remy S, Thepenier V, François V, et al. Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy. PLoS ONE. 2014;9:e110371 pubmed publisher
Malfatti E, Lehtokari V, Böhm J, De Winter J, Schäffer U, Estournet B, et al. Muscle histopathology in nebulin-related nemaline myopathy: ultrastrastructural findings correlated to disease severity and genotype. Acta Neuropathol Commun. 2014;2:44 pubmed publisher
Meinen S, Lin S, Ruegg M. Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-?2-deficient congenital muscular dystrophy (MDC1A). Skelet Muscle. 2012;2:18 pubmed publisher
Meinen S, Lin S, Thurnherr R, Erb M, Meier T, Ruegg M. Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice. EMBO Mol Med. 2011;3:465-79 pubmed publisher
Yuasa K, Nakamura A, Hijikata T, Takeda S. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle. BMC Musculoskelet Disord. 2008;9:1 pubmed publisher
Fukushima K, Nakamura A, Ueda H, Yuasa K, Yoshida K, Takeda S, et al. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ). BMC Musculoskelet Disord. 2007;8:54 pubmed
company information
Leica Biosystems
hrna@leica-microsystems.com
http://www.leicabiosystems.com